Back
GeneDx Holdings 10K Form
Sell
50
WGS
GeneDx Holdings
Last Price:
$72.29
Seasonality Move:
10.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive WGS News And Ratings
See the #1 stock for the next 7 days that we like better than WGS
WGS Financial Statistics
Sales & Book Value
| Annual Sales: | $305.5M |
|---|---|
| Cash Flow: | $4.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.02 |
| Price / Book: | 7.87 |
Profitability
| EPS (TTM): | -1.41000 |
|---|---|
| Net Income (TTM): | $-38.6M |
| Gross Margin: | $194.4M |
| Return on Equity: | -17.4% |
| Return on Assets: | -9.37% |
GeneDx Holdings Earnings Forecast
Key GeneDx Holdings Financial Ratios
-
The Gross Profit Margin over the past 6 years for WGS is 63.64%.
-
The Selling, General & Administrative Expenses for WGS have been equal to 55.16% of Gross Profit Margin.
-
The Research & Development expenses have been 14.97% of Revenue.
-
The Net Earning history of WGS is -17.12% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
GeneDx Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | WGS |
| Website: | genedx.com |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 3.25 |
| Quick Ratio: | 2.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 36.31 |
WGS Technical Analysis vs Fundamental Analysis
Sell
50
GeneDx Holdings (WGS)
is a Sell
Is GeneDx Holdings a Buy or a Sell?
-
GeneDx Holdings stock is rated a SellThe current GeneDx Holdings [WGS] share price is $71.02. The Score for WGS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.